126 related articles for article (PubMed ID: 27362730)
1. Cancer cell-derived 12(S)-HETE signals via 12-HETE receptor, RHO, ROCK and MLC2 to induce lymph endothelial barrier breaching.
Nguyen CH; Stadler S; Brenner S; Huttary N; Krieger S; Jäger W; Dolznig H; Krupitza G
Br J Cancer; 2016 Jul; 115(3):364-70. PubMed ID: 27362730
[TBL] [Abstract][Full Text] [Related]
2. Colon cancer cell-derived 12(S)-HETE induces the retraction of cancer-associated fibroblast via MLC2, RHO/ROCK and Ca
Stadler S; Nguyen CH; Schachner H; Milovanovic D; Holzner S; Brenner S; Eichsteininger J; Stadler M; Senfter D; Krenn L; Schmidt WM; Huttary N; Krieger S; Koperek O; Bago-Horvath Z; Brendel KA; Marian B; de Wever O; Mader RM; Giessrigl B; Jäger W; Dolznig H; Krupitza G
Cell Mol Life Sci; 2017 May; 74(10):1907-1921. PubMed ID: 28013338
[TBL] [Abstract][Full Text] [Related]
3. 12(S)-HETE increases intracellular Ca(2+) in lymph-endothelial cells disrupting their barrier function in vitro; stabilization by clinical drugs impairing calcium supply.
Nguyen CH; Brenner S; Huttary N; Li Y; Atanasov AG; Dirsch VM; Holzner S; Stadler S; Riha J; Krieger S; Milovanovic D; Fristiohardy A; Simonitsch-Klupp I; Dolznig H; Saiko P; Szekeres T; Giessrigl B; Jäger W; Krupitza G
Cancer Lett; 2016 Sep; 380(1):174-83. PubMed ID: 27390016
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumour spheroid-induced prometastatic intravasation gates in the lymph endothelial cell barrier by carbamazepine: drug testing in a 3D model.
Teichmann M; Kretschy N; Kopf S; Jarukamjorn K; Atanasov AG; Viola K; Giessrigl B; Saiko P; Szekeres T; Mikulits W; Dirsch VM; Huttary N; Krieger S; Jäger W; Grusch M; Dolznig H; Krupitza G
Arch Toxicol; 2014 Mar; 88(3):691-9. PubMed ID: 24352538
[TBL] [Abstract][Full Text] [Related]
5. In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen.
Kretschy N; Teichmann M; Kopf S; Atanasov AG; Saiko P; Vonach C; Viola K; Giessrigl B; Huttary N; Raab I; Krieger S; Jäger W; Szekeres T; Nijman SM; Mikulits W; Dirsch VM; Dolznig H; Grusch M; Krupitza G
Br J Cancer; 2013 Feb; 108(3):570-8. PubMed ID: 23299527
[TBL] [Abstract][Full Text] [Related]
6. AHR/CYP1A1 interplay triggers lymphatic barrier breaching in breast cancer spheroids by inducing 12(S)-HETE synthesis.
Nguyen CH; Brenner S; Huttary N; Atanasov AG; Dirsch VM; Chatuphonprasert W; Holzner S; Stadler S; Riha J; Krieger S; de Martin R; Bago-Horvath Z; Krupitza G; Jäger W
Hum Mol Genet; 2016 Nov; 25(22):5006-5016. PubMed ID: 28171546
[TBL] [Abstract][Full Text] [Related]
7. Feed‑back loops integrating RELA, SOX18 and FAK mediate the break‑down of the lymph‑endothelial barrier that is triggered by 12(S)‑HETE.
Engleitner S; Milovanovic D; Kirisits K; Brenner S; Hong J; Ropek N; Huttary N; Rehak J; Nguyen CH; Bago-Horvath Z; Knasmüller S; De Martin R; Jäger W; Krupitza G
Int J Oncol; 2020 Apr; 56(4):1034-1044. PubMed ID: 32319559
[TBL] [Abstract][Full Text] [Related]
8. Increase in cell motility by carbon ion irradiation via the Rho signaling pathway and its inhibition by the ROCK inhibitor Y-27632 in lung adenocarcinoma A549 cells.
Murata K; Noda SE; Oike T; Takahashi A; Yoshida Y; Suzuki Y; Ohno T; Funayama T; Kobayashi Y; Takahashi T; Nakano T
J Radiat Res; 2014 Jul; 55(4):658-64. PubMed ID: 24659807
[TBL] [Abstract][Full Text] [Related]
9. NF-κB mediates the 12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cells.
Vonach C; Viola K; Giessrigl B; Huttary N; Raab I; Kalt R; Krieger S; Vo TP; Madlener S; Bauer S; Marian B; Hämmerle M; Kretschy N; Teichmann M; Hantusch B; Stary S; Unger C; Seelinger M; Eger A; Mader R; Jäger W; Schmidt W; Grusch M; Dolznig H; Mikulits W; Krupitza G
Br J Cancer; 2011 Jul; 105(2):263-71. PubMed ID: 21629247
[TBL] [Abstract][Full Text] [Related]
10. Xanthohumol attenuates tumour cell-mediated breaching of the lymphendothelial barrier and prevents intravasation and metastasis.
Viola K; Kopf S; Rarova L; Jarukamjorn K; Kretschy N; Teichmann M; Vonach C; Atanasov AG; Giessrigl B; Huttary N; Raab I; Krieger S; Strnad M; de Martin R; Saiko P; Szekeres T; Knasmüller S; Dirsch VM; Jäger W; Grusch M; Dolznig H; Mikulits W; Krupitza G
Arch Toxicol; 2013 Jul; 87(7):1301-12. PubMed ID: 23503627
[TBL] [Abstract][Full Text] [Related]
11. In vitro characterisation of the anti-intravasative properties of the marine product heteronemin.
Kopf S; Viola K; Atanasov AG; Jarukamjorn K; Rarova L; Kretschy N; Teichmann M; Vonach C; Saiko P; Giessrigl B; Huttary N; Raab I; Krieger S; Schumacher M; Diederich M; Strnad M; de Martin R; Szekeres T; Jäger W; Dirsch VM; Mikulits W; Grusch M; Dolznig H; Krupitza G
Arch Toxicol; 2013 Oct; 87(10):1851-61. PubMed ID: 23543012
[TBL] [Abstract][Full Text] [Related]
12. Rho-kinase/myosin light chain kinase pathway plays a key role in the impairment of bile canaliculi dynamics induced by cholestatic drugs.
Sharanek A; Burban A; Burbank M; Le Guevel R; Li R; Guillouzo A; Guguen-Guillouzo C
Sci Rep; 2016 May; 6():24709. PubMed ID: 27169750
[TBL] [Abstract][Full Text] [Related]
13. Eicosanoid 12(S)-HETE activates phosphatidylinositol 3-kinase.
Szekeres CK; Trikha M; Nie D; Honn KV
Biochem Biophys Res Commun; 2000 Aug; 275(2):690-5. PubMed ID: 10964724
[TBL] [Abstract][Full Text] [Related]
14. Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability.
Sun H; Breslin JW; Zhu J; Yuan SY; Wu MH
Microcirculation; 2006; 13(3):237-47. PubMed ID: 16627366
[TBL] [Abstract][Full Text] [Related]
15. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.
Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
J Mol Neurosci; 2016 Jun; 59(2):193-202. PubMed ID: 26521255
[TBL] [Abstract][Full Text] [Related]
16. 12(S)-hydroxyeicosatetraenoic acid increases the actin microfilament content in B16a melanoma cells: a protein kinase-dependent process.
Rice RL; Tang DG; Haddad M; Honn KV; Taylor JD
Int J Cancer; 1998 Jul; 77(2):271-8. PubMed ID: 9650564
[TBL] [Abstract][Full Text] [Related]
17. Endosomes generate localized Rho-ROCK-MLC2-based contractile signals via Endo180 to promote adhesion disassembly.
Sturge J; Wienke D; Isacke CM
J Cell Biol; 2006 Oct; 175(2):337-47. PubMed ID: 17043135
[TBL] [Abstract][Full Text] [Related]
18. 12(S)-HETE induces lymph endothelial cell retraction in vitro by upregulation of SOX18.
Fristiohady A; Milovanovic D; Krieger S; Huttary N; Nguyen CH; Basilio J; Jäger W; De Martin R; Krupitza G
Int J Oncol; 2018 Jul; 53(1):307-316. PubMed ID: 29749465
[TBL] [Abstract][Full Text] [Related]
19. Targeting the metastasis suppressor, NDRG1, using novel iron chelators: regulation of stress fiber-mediated tumor cell migration via modulation of the ROCK1/pMLC2 signaling pathway.
Sun J; Zhang D; Zheng Y; Zhao Q; Zheng M; Kovacevic Z; Richardson DR
Mol Pharmacol; 2013 Feb; 83(2):454-69. PubMed ID: 23188716
[TBL] [Abstract][Full Text] [Related]
20. Thrombin promotes actin stress fiber formation in RPE through Rho/ROCK-mediated MLC phosphorylation.
Ruiz-Loredo AY; López E; López-Colomé AM
J Cell Physiol; 2011 Feb; 226(2):414-23. PubMed ID: 20672289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
